Andrographolide suppresses cervical cancer progression by targeting angiogenesis and inducing apoptosis in a CAM-PDX model. Biomol Biomed [Internet]. 2025 Feb. 11 [cited 2025 Oct. 21];25(8):1780–1788. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11432